Dicerna Pharmaceuticals, Inc.
METHODS FOR TREATING HEPATITIS B INFECTION
Last updated:
Abstract:
This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
Status:
Application
Type:
Utility
Filling date:
12 May 2021
Issue date:
16 Sep 2021